Acetate metabolism for bicarbonate generation

The acid-base balance mechanism involving systemic conversion of acetate to bicarbonate is a metabolic pathway crucial for maintaining acid-base homeostasis. This process is not a traditional drug target but a physiological function leveraged in clinical settings. Following administration or endogenous production, the acetate anion forms acetyl-CoA, enters the citric acid cycle, producing carbon dioxide and water. Carbonic anhydrase rapidly converts these products into bicarbonate. This metabolism of acetate effectively increases the strong ion difference, contributing to alkalemia and buffering acidosis. This pathway plays roles in acid-base homeostasis, pH buffering, energy production, and metabolic adaptation. Clinically, acetate salts and sodium acetate are used in parenteral nutrition, as alternatives to sodium bicarbonate, in balanced crystalloid solutions like Plasma-Lyte, and in hemodialysis to correct metabolic acidosis. Metabolic considerations include significant metabolism in skeletal muscle (not primarily hepatic), unaffected handling in liver disease, and variability in metabolic capacity (especially lower in some women, approximately 10% of hemodialysis patients). Acetate sources include gut bacterial metabolism, diet, alcohol, protein deacetylation, and de novo synthesis. Safety concerns include metabolic alkalosis from excessive acetate relative to chloride, adverse events associated with sodium acetate overload, and the risk of elevated plasma acetate in individuals with reduced metabolic capacity.

Other names

Acetate to bicarbonate conversionAcid-base balance via acetateAcetate buffering

Acetate is converted to acetyl-CoA, enters the citric acid cycle generating CO2 and H2O, which are then rapidly converted to bicarbonate via carbonic anhydrase. This process increases the strong ion difference, leading to an increase in blood pH (alkalemia). This mechanism describes the metabolic pathway itself, which is leveraged therapeutically, rather than a drug acting on a specific target molecule within the pathway.